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ABSTRACT: Tubular scaﬀolds which incorporate a variety of micro- and
nanotopographies have a wide application potential in tissue engineering
especially for the repair of spinal cord injury (SCI). We aim to produce
metabolically active diﬀerentiated tissues within such tubes, as it is crucially
important to evaluate the biological performance of the three-dimensional (3D)
scaﬀold and optimize the bioprocesses for tissue culture. Because of the
complex 3D conﬁguration and the presence of various topographies, it is rarely
possible to observe and analyze cells within such scaﬀolds in situ. Thus, we aim
to develop scaled down mini-chambers as simpliﬁed in vitro simulation systems,
to bridge the gap between two-dimensional (2D) cell cultures on structured
substrates and three-dimensional (3D) tissue culture. The mini-chambers were
manipulated to systematically simulate and evaluate the inﬂuences of gravity,
topography, ﬂuid ﬂow, and scaﬀold dimension on three exemplary cell models
that play a role in CNS repair (i.e., cortical astrocytes, ﬁbroblasts, and myelinating cultures) within a tubular scaﬀold created by
rolling up a microstructured membrane. Since we use CNS myelinating cultures, we can conﬁrm that the scaﬀold does not aﬀect
neural cell diﬀerentiation. It was found that heterogeneous cell distribution within the tubular constructs was caused by a
combination of gravity, ﬂuid ﬂow, topography, and scaﬀold conﬁguration, while cell survival was inﬂuenced by scaﬀold length,
porosity, and thickness. This research demonstrates that the mini-chambers represent a viable, novel, scale down approach for the
evaluation of complex 3D scaﬀolds as well as providing a microbioprocessing strategy for tissue engineering and the potential
repair of SCI.
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■ INTRODUCTION
Injury to the central nervous system (CNS) is devastating for
the patient and in general is irreversible. Strategies to repair the
damaged CNS are complex and challenging, and it is thought
that the best approach is to use a combination of treatments
including cell transplantation and pharmacological treatments.1
One of these includes the use of biodegradable bridges or
scaﬀolds to bridge the lesion and encourage neurons and glial
cells to cross into the noninjured tissue.2 However, to assess if
these scaﬀold prototypes can promote the survival and
diﬀerentiation of CNS cells across a lesion is diﬃcult as they
would require in vivo models. Therefore, the use of cell cultures
that mimic the target CNS tissue would beneﬁt the develop-
ment of potential scaﬀolds. The major strength of cell culture
compared to in vivo work is their simplicity and accessibility.
For example, cultures allow the study of many parameters over
a relatively short period of time but in general cannot replicate
the complex architecture and local environment of endogenous
tissue. However, with the advancement of three-dimensional
(3D) culture systems intending to mimic tissue architecture
and speciﬁc organs or tissues, e.g., bone, or even to mimic
critical systems of an entire organism, e.g., human on a chip,3
the development and testing of increasingly complex cultures
can mimic aspects of animal models and be used as a pre-test
on potential scaﬀolds before use in vivo.
Previously, we have developed a method of fabricating
tubular constructs (coined Swiss-roll; Figure 1A) with potential
applications in vascular and nerve tissue engineering.4,5 The
Swiss-rolls were made of a thin (<30 μm) biodegradable ε-
polycaprolactone (PCL) membrane6 with nano- and/or
microtopographies on either (both) side(s) to guide, promote,
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or inhibit speciﬁc cellular responses.7−9 Other microstructures
such as microspacers and or open pores were also included to
increase scaﬀold porosity for nutrient and waste diﬀusion since
the success of tissue engineering is also dependent on the
maintenance of mass transport throughout the scaﬀold after cell
colonization.10−12 The assumptions that underpin the Swiss-
roll design were derived from cell cultures on two-dimensional
(2D) structured substrates.13 Since a variety of new elements
(grooves, pores, and pillars to separate the layers) were
combined in the tubular construct, it was crucially important to
optimize the dimension and placement of these features, and
evaluate their performances before the scaﬀold could be used
for tissue engineering. However, due to the complex 3D
conﬁguration and other factors such as its large size, multiple
layers, micro-, nanotopographies, and the translucency of the
PCL material, it was almost impossible to investigate various
cell behaviors within the scaﬀold in situ. Although conventional
cell analysis methods such as biochemical analysis, histology,
and or immunostaining can be used posthoc at predetermined
time-points, the cells or tissues have to be sacriﬁced. The fragile
cell structures inside the scaﬀold will be damaged during
procedures such as ﬁxation, embedding with highly viscous
media, cutting, and staining; thus, vital information about cell
morphology and distribution within diﬀerent parts of the
scaﬀold could be lost.
Our observation of uneven cell distribution throughout the
Swiss-rolls (see Figure 1B) led us to believe that ﬂuid ﬂow,
gravity, topography, and overall 3D conﬁguration could
inﬂuence cell distribution within, but this could not be easily
investigated using this scaﬀold. Thus, the aim of this research
was to develop a novel scale down approach for the systematic
evaluation of cell behavior within the tubular 3D scaﬀold. Mini-
chambers with two or more layers of PCL substrates, with
diﬀerent microstructure, and/or diﬀerent lengths were
fabricated and used as simpliﬁed simulators of speciﬁc parts
or conﬁgurations of the whole scaﬀold (Figure 1C,D). By
manipulating the chambers, the direction of gravity and ﬂuid
ﬂow within the tubular scaﬀolds could be simulated and their
eﬀect on cell adhesion and survival could be evaluated (Figure
1E,F).
In order to maintain the generality and transferability of this
research, and also because of the potential application of the
Swiss-rolls to various areas of tissue engineering, several
diﬀerent cell types were selected. As one of the major
supportive glial cell types in the central nervous system
(CNS),13,14 type 1 cortical astrocytes were selected as an
exemplary cell type that would encounter structures in CNS
tissue engineering. hTERT ﬁbroblasts were selected because
ﬁbroblasts play important roles in structure formation and
various wound healing processes.15,16 With a focus on the
potential application of the tubular scaﬀold to be used as a
bridging/vector delivery device in the treatment of SCI, where
the main aim is to encourage axonal outgrowth and the
subsequent myelination of these process, we used complex
mixed CNS cultures. These consist of dissociated embryonic rat
spinal cord cells plated on neurosphere derived astrocytes,
which develop to form axons myelinated with internodes of
myelin separated by the node of Ranvier as seen for CNS tissue
in vivo.13,17,18 Moreover, as these cultures mimic complex
neural cell interactions from astrocyte reactivity to myelination,
they are useful for determining how pharmacological/drug
treatments and scaﬀolds can inﬂuence these aspects of CNS
repair.
Investigations of these various cells within the mini-chambers
indicated that the distribution of these cells within the tubular
constructs was inﬂuenced by a combination of gravity, ﬂuid
ﬂow, topography, and scaﬀold conﬁguration, while cell survival
was inﬂuenced by the length, porosity, and thickness of the
construct. The number of scaﬀold layers and the presence of
pores in the lid of the mini-chambers also had eﬀects beyond
cell survival, with neurite extension and myelination reduced in
the myelinating cultures plated on mini-chamber in the absence
of pores.
■ EXPERIMENTAL SECTION
Cell Culture. Astrocytes. Puriﬁed type 1 cortical astrocytes
were prepared as described previously14,19 by ﬁrst digesting
cortices (dissected from 1-day old Sprague−Dawley rats) in
1.33% collagenase (Sigma, Poole, UK), seeding (∼2 × 107 cells
per T75 ﬂask), and culturing the cells in a poly-L-lysine coated
T75 ﬂask for 10−12 days. The cells were maintained in DMEM
(Invitrogen, Paisley, Scotland) supplemented with 10% fetal
bovine serum (FBS) (Invitrogen, Paisley, Scotland) and L-
glutamine (2 mM, Sigma). Conﬂuent ﬂasks were shaken on a
rotary platform overnight at 37 °C to remove contaminating
oligodendrocyte progenitor cells. The remaining cells after this
procedure were 85−95% type 1 cortical astrocytes, as judged by
labeling for glial ﬁbrillary acidic protein (GFAP), which is a cell-
type speciﬁc marker for astrocytes. The astrocytes were
passaged no more than 4 times and detached using trypsin/
EDTA (0.02% solution) for experiments when almost 100%
conﬂuent.
Fibroblasts. hTERT ﬁbroblasts (immortalized from primary
human BJ foreskin ﬁbroblasts, Clontech Laboratories, Inc.
USA) were cultured using the same medium as astrocytes and
detached for experiments when approximately 90% conﬂuent as
previously described.20
Figure 1. (A) Scanning electron microscope image of the tubular PCL
Swiss-roll construct. (B) Astrocyte distribution within the tubular
construct after 2 weeks of culture. The Swiss-roll was unrolled for
imaging. Scale bar = 2 mm. (C) Mini-chambers with deﬁned width (1
cm) and diﬀerent lengths (1.0, 1.5, 2.5, 3.0 cm). (D) Mini-chambers
(1 cm wide, 3.0 cm long) with 1, 2, 3, and 6 layers of porous lids. (E)
The appearance of the mini-chambers (1 cm wide, 2.5 cm long) with
connected silicone tubes as used for time-lapse experiments. (F)
Schematic diagram of the cross-sections of a Swiss-roll and mini-
chambers rotated accordingly, illustrating how these simulate various
positions within the Swiss-roll.
Molecular Pharmaceutics Article
dx.doi.org/10.1021/mp400526n | Mol. Pharmaceutics 2014, 11, 2143−21502144
Myelinating Cultures. The myelinating cultures were
prepared as previously described.13,17 Brieﬂy, neurospheres
were generated from the striatum of P1 Sprague−Dawley rats
and cultured in neurosphere media (DMEM/F12 (1:1), 0.6%
glucose, 2 mM glutamine (Invitrogen), insulin (25 mg/mL,
Sigma, Poole Dorset, U.K.), 5 mM Hepes (Sigma), 0.105%
NaHCO3 (Sigma), 5000 IU/mL penicillin (Invitrogen), 5 mg/
mL streptomycin (Invitrogen), 100 mg/mL apotransferrin
(Sigma), 20 nM progesterone (Sigma), 60 mM putrescine
(Sigma), and 30 nM sodium selenite (Sigma) supplemented
with 20 ng/mL mouse submaxillary gland epidermal growth
factor (EGF, R&D systems, Abingdon, U.K.) and cultured as
neurospheres for 7−10 days at 37 °C and 7% CO2, with
supplementation of the media every alternate day. For
generation of the myelinating cultures, the neurospheres were
diﬀerentiated into astrocytes by treatment with DMEM
containing 10% FBS in a ﬂask prior to plating. Spinal cord
cells from E15 Sprague−Dawley rat embryos were generated by
enzymatic digestion, seeded onto astrocyte monolayers at
150,000 cells per 100 μL, and left for 2 h at 37 °C and 7% CO2
before feeding with a mix of plating media and diﬀerentiation
media (DMEM 196966, Invitrogen, 50 nM hydrocortisone, 10
ng/mL biotin 4 μM progesterone (Sigma), 20 mM putrescine
(Sigma), 6 μM selenium (Sigma), and 1 m/mL apotransferrin
(Sigma)) supplemented with 10 μg/mL insulin. The cultures
were maintained by replacing 50% of the existing media with
fresh diﬀerentiation media on alternate feeding days, and after
12 days the insulin supplement was removed for the remainder
of the culture duration.
Fabrication of PCL Membranes. There were two steps to
fabricate porous ε-polycaprolactone (PCL, Mw 65 000 Da, CAS
24980-41-4, Aldrich, Poole, U.K.) membranes.4,21 A silicon
wafer with microfabricated SU-8 microgrooves (25 μm pitch; 5
μm depth) and micropillars (height, 30 μm; diameter, 300 μm;
distance between each pillar, 300 μm) was spin-coated (1500
rpm, 30s) with 25% (w/v) PCL chloroform solution. After the
chloroform had evaporated, a porous PCL sheet (10−15 μm
thick; pore size, 300 μm in diameter) could be peeled oﬀ the
silicon wafer. The same procedure was adapted to fabricate ﬂat
PCL membranes using a smooth silicon wafer without any
structures.
Design and Fabrication of Mini-chambers. The mini-
chambers were fabricated by ﬁrst hot-embossing and attaching
a piece of ﬂat PCL membrane onto a plastic carrier as the base
and then ﬁxing another piece of PCL membrane on top of it as
the lid. Brieﬂy, the ﬂat PCL membrane (1.5 cm × 3 cm) was
trimmed and spread on the structured side of a poly
dimethylsiloxane (PDMS) stamp4,20 and then sandwiched by
a piece (1.5 cm × 3 cm) of Aclar (Agar Scientiﬁc, Stansted,
U.K.) that acted as a carrier. The sandwich was pressed gently
on a hot plate (80 °C) for 20−30 s. The microstructures were
thus imprinted into the molten PCL polymer, which was
simultaneously glued onto the plastic carrier. After cooling to
room temperature for 3−5 min, the base (i.e., plastic carrier
with the microstructured PCL membrane) was carefully peeled
oﬀ the stamp and treated with Harrick Plasma Cleaner (Harrick
Plasma, USA) at Hi settings (740 V DC, 40 mA DC, and 29.6
W) for 5 min. A piece of plasma treated ﬂat or porous PCL
membrane (1.5 cm × 3 cm) was then spread evenly on top of
the microstructured base as the lid. Both the base and the lid
were heat sealed together by adding a 1 cm wide spacer and
using the 1.5 mm wide edges of two preheated glass slides (100
°C) to melt the lid onto the base for 1−2 min. Using diﬀerent
microstructured bases and lids, a variety of chambers were
designed and fabricated. In this research, bases with two types
of microstructures were used: (A) grooved/pillared bases with
an alternating pattern of parallel grooves, ridges with the same
width (25 μm) and depth (5.0 μm), and rows of pillars (pillar
size, 50 μm wide, 400 μm long, and 75 μm high; distance
between pillars in each row, 100 μm; row to row distance, 400
μm) and (B) pillared bases with only rows of pillars (the same
dimension and spacing as those above). Flat and porous PCL
membranes without any topography were used as the lids.
Chambers with multiple porous lids were also prepared by
repeating the procedure of lid fabrication. As illustrated in
Figure 1, mini-chambers of diﬀerent lengths (Figure 1C) with
diﬀerent numbers of porous lids (Figure 1D) were fabricated.
These could be rotated at diﬀerent angles to simulate diﬀerent
parts of the tubular construct (Figure 1F). For time-lapse
experiments, a thin silicone tube (diameter, outer 1 mm; inner
0.3 mm) was connected to the mini-chamber by inserting it
into one end of it. The lid and base were then fused together
using the edge of a hot glass slide (100 °C). The connection
between the silicone tube and the mini-chamber was further
sealed using 25% PCL in chloroform (w/v) as glue. The other
end of the silicone tube was connected to a syringe via a Luer
lock (Figure 1E) for cell seeding or medium change.
Cell Culture within the PCL Mini-chambers. Prior to cell
culture, all of the mini-chambers were sterilized in 70%
ethanol/sterile water (v/v) overnight, washed thoroughly with
phosphate buﬀered salt solution (PBS) and sterilized reverse
osmosis (RO) water, and dried. For ﬁbroblasts and cortical
astrocytes, cells were seeded into a mini-chamber by separating
the lid and the base, creating a small gap in between each by
gently bending the plastic carrier. After seeding approximately
50 μL of cell suspension (0.5−2 × 106 cells/mL) into the gap,
the mini-chamber was kept horizontally, released slowly to its
original shape to spread the cell suspension inside the chamber,
then placed or rotated in a Petri-dish or a 6-well-plate at 37 °C
for 0.5 to 2 h to allow full cell attachment. This was followed by
adding 3 mL of media to the Petri dish or 6-well plate for
subsequent cell culture in an incubator (37 °C and 5% CO2).
During culture, the media in the Petri dish or 6-well plate were
changed twice a week. For time-lapse experiments, mini-
chambers with a silicone tube connector were attached to the
stage of an inverted phase contrast microscope (Zeiss Axiovert
25, Carl Zeiss), which was mounted on a hinge like base plate,
and thus could easily be tilted to any angle. Here, we used 45°
or 90° to mimic diﬀerent aspects of the Swiss-roll. The mini-
chambers were continuously imaged during and after seeding
cells into the chamber through a syringe.
For myelinating cultures, initial cell seeding was with
striatum-derived astrocytes at 1 × 106, with the mini-chambers
being submerged in 10% FBS after 30 min and cultured
overnight at 37 °C and 7% CO2 for 18 h. The following day,
the dissociated E15 spinal cord was added to the mini-
chambers that had been preseeded with astrocytes, using the
same protocol as that for ﬁbroblasts/cortical astrocytes but
using the myelinating culture media and feeding regimen.12
Cell Assessment. Coomassie Staining. Cells were washed
with 37 °C warm PBS, ﬁxed in 4% formaldehyde in PBS (pH
7.4), and stained with Commassie Brilliant blue (R-250,
dissolved in 30% methanol, 30% acetic acid, and 40% RO
water) for 15 min, washed with destain (10% methanol in RO
water), and imaged using bright ﬁeld optics (Zeiss Axiovert
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200M, Wetzlar, Germany, QEi evolution camera, Media
Cybernetics, Marlow, U.K.).
MTT Assay. Metabolic cell activity was analyzed using the
MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium
bromide, Sigma) assay with slight modiﬁcations. Brieﬂy, cells
within the chambers were washed thoroughly with PBS and
incubated in MTT solution (0.5 mg/mL MTT in PBS) for 60
min at 37 °C. To evaluate cell viability in diﬀerent chambers,
the whole chambers with MTT stained cells were ﬁrst imaged,
then the percentage of viable cell colonies within each chamber
(cell density) was analyzed using ImageJ and compared. To
evaluate cell viability in diﬀerent parts of the same chamber,
each chamber was ﬁrst divided into rectangular areas (0.33 cm
×1 cm) and labeled starting from the central area with 0 and
increasing toward both ends (e.g., 1, 2, 3, and 4). The images of
each area were analyzed using ImageJ for cell density and
compared. For comparison purposes, all of the chambers in the
following assessments were also divided into rectangular areas
(0.33 cm × 1 cm) and labeled as described above.
Statistics. For the MTT assay, the data for 3 technical
repeats were collected, normalized against an open control,
averaged, and the average and standard deviation of three
independently repeated experiments calculated. The resulting
data were compared using Student’s t test.
Immunocytochemistry. Cells were ﬁxed in 4% paraformal-
dehyde and permeabilized with PBS containing 0.2% (w/v)
gelatin and 0.1% (v/v) Triton X-100. The primary antibodies
used for labeling were SMI-31, which labels phosphorylated
neuroﬁlament and nerve processes (mouse monoclonal,
Abcam), AA3, which labels the late myelin marker proteolipid
protein (PLP-DM20),22 which was a gift from S. Pfeiﬀer,
University of Connecticut, USA), and GFAP (rabbit polyclonal,
DAKO, Denmark). The secondary antibodies used were all
purchased from the Alexa Fluor range (Invitrogen). Nuclei
were visualized using DAPI, which was included in the hard set
mountant (Fluoro-Gel, Interchim, France).
Imaging. Images were captured using an Olympus BX51
microscope with Q imaging software. Images were processed in
Image Pro Plus (Media Cybernetics) for use in subsequent
myelination analysis.
Quantiﬁcation of Myelination. For more details on the
quantiﬁcation of myelination, refer to ref 17. Brieﬂy, images of
the myelinating cultures labeled with SMI-31 and anti-PLP
were initially opened using Image J and the blue (DAPI)
channel removed, followed by the red (for axons) and green
(for mature myelin) image being opened with Adobe
Photoshop Elements 7.0. The myelin sheath was drawn over
using a brush stroke in blue using a new, lightened layer and a
value in pixels obtained. The density of neurites was calculated
using the value for the red pixels in Image J and the percentage
of myelination (amount of red neurites covered in blue myelin
sheath) calculated. In this manner, quantiﬁcation of only the
myelin sheath was made, and the quantiﬁcation of any
immunoﬂuorescence associated with PLP expressing oligoden-
drocytes, which had no ensheathed axons, was not considered.
Experiments were carried out thrice in duplicate.
Statistical Analysis. Statistical analysis on the myelinating
cultures were carried out using Student’s t test.
■ RESULTS
Inﬂuence of Chamber Length on Cell Survival. Cell
Density and Viability. Mini-chambers of a ﬁxed width (1 cm)
and diﬀerent lengths (1.0, 1.5, 2.5, and 3.0 cm) were seeded
with astrocytes (0.5 × 106 cells/mL) and placed horizontally
within 6-well plates for 3 weeks of culture. As shown in Figure
2A,B, the length of the chamber had obvious inﬂuences on cell
survival as a signiﬁcantly higher density of viable cells was
measured within short (1 cm) chambers compared to longer
(>1.5 cm) chambers. Moreover, viable cells tended to
concentrate at the open edges of the longer chambers, while
being distributed uniformly in the shorter (1 cm) chambers.
Similar results were obtained with ﬁbroblasts (data not shown).
Inﬂuence of Scaﬀold Thickness on Cell Survival.
Porous PCL lids were fabricated to simulate Swiss-rolls with
diﬀerent thicknesses. Mini-chambers (1 cm wide and 3.0 cm
long) with 1 layer of ﬂat PCL as a lid were used as the controls
and stained with MTT. Astrocytes (0.5 × 106 cells/mL) were
Figure 2. (A,B) Representative images of MTT stained astrocytes at 21 DIV within mini-chambers of diﬀerent lengths (1−3 cm), showing along the
top the diﬀerent positions of the 0.33 cm wide analysis windows (0 at the center, maximum; four at the periphery) and below their corresponding
graph symbols in B. (B) Graph showing the density of MTT stained astrocytes within each analysis window along the mini-chambers. (C)
Representative images of MTT stained astrocytes at 21 DIV in 3 cm long mini-chambers with between 1 (I) and a maximum of 6 (VI) porous lids
and a nonporous lid (C). (D) Graph of MTT density correlates directly to that of viable cells within the mini-chambers shown in (C). All results
shown (B,D) are the mean ± SD (n = 3).
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seeded into these chambers, cultured for 3 weeks, and then
stained with MTT. As shown in Figure 2C, there were
signiﬁcantly more viable cells in the chamber with porous lid(s)
than in the control chambers. However, much less viable cells
were detected within the chambers with 6 layers of porous lids
compared with the chambers with 1−3 layers of porous lids,
suggesting that scaﬀold thickness will have a signiﬁcant
inﬂuence on cell survival within the Swiss-rolls. These results
demonstrated that open pores are an eﬀective approach to
circumvent the limitation of mass transfer. However, its
eﬃciency was compromised if multiple layers were used in
3D scaﬀolds. Thus, other approaches such as perfusion culture
might be necessary to enable better mass transfer especially
within thick or multilayered scaﬀolds.
Myelinating Cultures. As demonstrated by the mini-
chambers containing only cortical astrocytes, culture viability
and cell density of the mixed myelinating cultures were aﬀected
by the length of the mini-chamber, with only mini-chambers of
0.5 cm length demonstrating viable cultures at 28 days (data
not shown). In mini-chambers with a nonporous PCL lid, there
was no cell survival whatsoever in chambers beyond 1 cm in
length (Figure 3A) and very poor viability (max 10% neurite
density in any region) in mini-chambers of 1 cm in length.
However, the inclusion of pores into the mini-chambers’ PCL
lid enabled the survival of a viable myelinating culture in
scaﬀolds of up to 2.5 cm in length (Figure 3B). Unlike that seen
for single cell cultures in mini-chambers with nonporous lids,
the neurite density was comparable throughout the length of
the mini-chamber, with no preference for either edge (Figure
3C).
Eﬀect of Pores on Myelination. Myelinating cultures
were seeded into mini-chambers of 0.5 cm length, with porous
or nonporous lids, and maintained for at least 28 days in vitro
(D.I.V.). The inclusion of pores in the lids, although not
essential for the survival of the myelinating cultures, with a
comparable neurite density observed between the two
conditions (Figure 4C) demonstrated a signiﬁcant enhance-
ment of the levels of myelination (t test, n = 3, p < 0.05)
compared with that of mini-chambers of possessing nonporous
lids (Figure 4D). In cultures expanded beyond 28 D.I.V. this
diﬀerence was still detectable (Figure 4A,B)
Inﬂuence of Gravity, Chamber Orientation, Micro-
structure, and Fluid Flow on Cell Distribution. Mini-
chambers with grooved/pillared bases, ﬂat PCL lids, and
deﬁned size (1 cm wide, 2.5 cm long, and 70 μm high) were
divided into 4 groups for the diﬀerent angles. After seeding with
ﬁbroblasts/astrocytes (0.5 × 106 cells/mL), they were
immediately placed in 6-well plates and rotated to diﬀerent
angles (0°, 45°, 90°, and 180°). After incubation at 37 °C and
95% air/5% CO2 for 1 h, the cells were ﬁxed, stained with
Coomassie blue, and imaged to analyze cell distribution. As
shown in Figure 5A, when the chambers were placed
horizontally (0° or 180°), cells were always detected on the
substrates that faced upward even though the gap between the
two substrates was only about 75 μm. When the chambers were
rotated to 45°, cells adhered all over the upward facing side,
with slightly more cells toward the lower part of the mini-
chamber. More cells were also observed on the sides of the
pillars facing up, while microgrooves had no obvious inﬂuence
on cell distributon (Figure 5B). When chambers were rotated
to 90°, most of the cells could be found concentrated in the
Figure 3. (A) Representative images of a myelinating culture at
diﬀerent locations inside a 2.5 cm mini-chamber possessing a
nonporous lid showing poor viability of cultures. (B) Representative
images of a myelinating culture inside a 2.5 cm mini-chamber
possessing a porous lid at diﬀerent locations. (C) Graph showing
mean neurite density (SMI-31 immunoreactivity), an indicator of
myelinating culture viability, in each location of the 2.5 cm long mini-
chamber possessing a porous lid (gray bars) and nonporous lid (black
bars). All images are at 28 D.I.V., and the graph is representative of this
time point. Scale bar: 100 μm. 0−3 represents locations as illustrated
in Figure 2. SMI-31 (red for axons); PLP (green for myelin).
Figure 4. (A,B) Representative images of myelinating cultures within a
0.5 cm long mini-chamber at both 28 D.I.V. and 46 D.I.V. (A) with a
nonporous lid and (B) with a porous lid. All images were labeled for
SMI-31 (red) and PLP (green). Graphs show neurite density (C) and
percentage of myelination (D) for the myelinating cultures at 28 D.I.V.
n = 3. Scale bar: 100 μm.
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lower part of the mini-chamber, with very few cells in the
middle part, and almost no cells could be observed in the upper
part of the mini-chamber. More cells were again detected on
the sides of the pillars that faced up, and microgrooves had no
obvious inﬂuence on cell distributions.
To investigate how ﬂuid ﬂow inﬂuences cell distribution and
how it interacts with gravitation, ﬁbroblasts (2 × 106 cells/mL)
were seeded into tube-connected chambers (1 cm wide and 2.5
cm long) on a tilted (45° or 90°) time-lapse microscope and
videoed. As shown in Figure 5C, when the chambers were
placed vertically (90°) most of the cells were observed to
quickly ﬂow toward the lower part of the mini-chamber. Within
20 min after cell seeding, very few cells remained attached to
the pillars, and those which did only attached to the upper sides
(with respect to ﬂow and gravity). When the chambers were
rotated to 45°, some cells were still observed to ﬂow downward,
but most attached to the base within 10 min. Compared with
microgrooves, micropillars also inﬂuenced cell distribution as a
substantial number of cells adhered to the upper-sides of the
pillars. However, when the long axis of the micropillars was
placed in line with respect to ﬂuid ﬂow and gravity, the pillars’
inﬂuence on cell distribution was reduced signiﬁcantly. Similar
results were obtained with astrocytes (data not shown).
■ DISCUSSION
In this study, novel scaled down mini-chambers were developed
to evaluate how cells interact with our previously fabricated
tubular scaﬀold, with several important cell responses identiﬁed
and tested.23 It is accepted that a major problem with 3D
culture systems is the survival of cells within the culture itself,
with oxygen and nutrient depletion leading to a proportional
necrosis of the cells, based upon their distance from the edge of
the 3D system.11 The mini-chambers, due to their conﬁg-
uration, also demonstrated this eﬀect on cell survival in the
absence of a porous lid, as demonstrated by the variable cell
density in mini-chambers of diﬀerent length, with the
preference of cells to be located in areas proximal to the edges.
This eﬀect is even more extreme when a complex CNS
culture is added, with the entirety of cells in the culture
consistently dying out in mini-chambers over 0.5 cm in length.
This is most likely due to the limitations of mass transfer within
the mini-chambers, which we investigated by observing Trypan
blue diﬀusion (data not shown), where the dye was present in
the longer mini-chambers for up to a week after media change.
This limitation could be overcome by the inclusion of pores
within the mini-chamber lid with signiﬁcantly greater cell
survival in mini-chambers of all lengths compared with mini-
chambers lacking a porous lid. Again, when a complex CNS
culture was present, the relevance of the eﬀects of the pores was
even more apparent, with a consistent neurite density extending
throughout the entire mini-chamber, a feature of importance
for the tubular scaﬀold’s primary purpose as a conduit for
axonal growth through CNS injury sites.
The inclusion of pores also had an eﬀect beyond simply
enhancing the survival of the cells within the mini-chambers,
with a signiﬁcant enhancement of myelination within the
myelinating cultures seeded into mini-chambers with porous
lids. However, the neurite density between the two cultures was
comparable, and cultures could be maintained in mini-
chambers with both porous and nonporous lids for extended
culture periods (46 D.I.V.) with no loss of neurite density. This
suggests that the nutrient transfer permitted by the pores is
important for critical processes undergone by the cells within
the mini-chambers and, by extrapolation the tubular scaﬀold, by
suggesting that diﬀerent processes have diﬀerent thresholds of
nutrient requirements.
The seeding experiments with the diﬀerent angles of the
mini-chambers suggested that the inﬂuence of gravity will play a
critical role in the seeding of the cells into the tubular scaﬀold,
which would possess a surface angled at every degree of
rotation. The results illustrated the inﬂuences that chamber
rotation, 3D conﬁguration, micropillars, and gravity had on the
distribution of the cells within mini-chambers or indeed Swiss-
rolls.
Figure 5. (A) Coomassie blue stained cultures illustrating the inﬂuence of gravity on the distribution of ﬁbroblasts within horizontally (0° or 180°)
placed mini-chambers, 1 h after seeding. (B) Coomassie blue stained cultures illustrating the inﬂuence of gravity on the distribution of ﬁbroblasts
within tilted (45°, 90°) mini-chambers, 1 h after seeding. (C) The inﬂuence of ﬂuid ﬂow, microstructure, chamber orientation, and gravity on the
distribution of cells within mini-chambers tilted at 45° or 90° over time. The black arrows indicate the direction of gravity (g), and the white arrow
indicates the direction of ﬂuid ﬂow (f). The micrographs to the right in the same row were taken at diﬀerent time points (0, 10, 20, and 40 min). The
schematic diagram of the chamber cross-section to the left in each row illustrates the mini-chamber orientation, and the gray frame indicates at which
layer the micrograph to the right in the same row was taken after the cells were introduced. Scale bar: 100 μm.
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All of these observations demonstrated that the distribution
of cells freshly introduced into the tubular 3D scaﬀolds was
inﬂuenced by various factors including gravity, scaﬀold
conﬁguration, “larger” topographies such as the micropillars,
and ﬂuid ﬂow. It was almost impossible to achieve uniform cell
distribution by simply loading the tubular construct with a cell
suspension. As gravity, scaﬀold orientation, and conﬁguration
were demonstrated to be the main causes for heterogeneous
cell distribution, approaches to circumvent their inﬂuences
might be necessary to achieve uniform cell distribution.
In summary, the mini-chambers demonstrated the capacity to
support complex cultures of cells while isolating individual
components of a complex 3D scaﬀold design in an environment
where they are more accessible for analysis. As a simple 3D
model, the mini-chambers displayed various technical and
operational advantages: First of all, they are cost-eﬀective.
Multiple chambers can be employed for intensive in parallel
experiments, as they are cheap and easy to fabricate. Second,
they are very adaptable. Mini-chambers with diﬀerent sizes,
multiple lids, and a variety of chemical, micro/nanotopographic
features can be designed and fabricated enabling the simulation
of more complex 3D scaﬀolds with diﬀerent lengths,
thicknesses, and complex internal features. Third, they are
easy to use. Cells can be easily seeded using a micropipet or
injected using an attached tube into the chambers, which will be
rotated to diﬀerent angles within Petri dishes or 6-well plates to
simulate various conﬁgurations and orientations of a 3D
scaﬀold during cell culture. Because of the adaptation of two
layers, various behaviors of living cells can be investigated in
situ; as the chambers can be integrated with light microscopy, it
is possible to directly observe during culture.
Moreover these mini-chambers charged with complex neural
cells represent a simpliﬁed version of the 3D environment, as
well as the cells that would be involved in CNS repair and
encountered in vivo. Thus, these devices allow the in-depth
study of cellular interactions, drugs, and scaﬀolds in vitro and
limit the necessity for in vivo studies by allowing prescreening of
various potentially useful combinations of cells, drugs, and
speciﬁc scaﬀold parameters. In addition, they allow the
mimicking of eﬀects of nutrient and oxygen deprivation on
basic parameters such as cell adhesion, proliferation, and
survival. With various scaﬀold modiﬁcations, the cells can have
progressively less potential to spread and proliferate with
increasing numbers of lids or toward the center of a closed lid
chamber. Deprivation of these factors also inﬂuences the more
subtle parameters of axon extension, as well as oligodendrocyte
diﬀerentiation and myelination. These chambers, therefore,
could form a suitable in vitro test system for the inﬂuence of
drugs targeted at repair under conditions where the access to
nutrients is limited over prolonged periods of time (e.g.,
stroke). The most widely used in vitro model for stroke is
oxygen nutrient (glucose) deprivation using a combination of
low oxygen tension or an inhibitor of oxidative phosphorylation
with desoxyglucose as a replacement for glucose. Here, the
physical barrier to nutrient and oxygen access, in combination
with the volume restriction to a ﬂuid layer of only 50 μm in
height, which although small compared to tissue culture dishes
(mm) is much larger than the submicrometer sized free space
between cells in the nervous tissue,24 is probably essential in
contributing to this potential model. The space under the lid
(50 μm) closely resembles the average distance between
capillaries in the CNS (40−130 μm25). Considering the lactic
acid production by, e.g. ﬁbroblasts 40pmol/cell/h, and the
volume under the lid over an area of about 1−4 cells (50 × 50
μm), glucose (5 mM = 0.875 pmol) would have been used up
within minutes.26 The ability of the devices to be connected up
to, e.g., a syringe pump, would also allow experimenters to
mimic the cellular environment in greater detail and investigate
the relevance of ﬂuid ﬂow (which in the interstitium is ca. 0.6
μm/h27) to drug delivery and clearance, as well as to the study
of reperfusion injury. The detailed control over the pore size
and position would allow local access to nutrients and oxygen
as well as the disposal of waste products to be tightly
controlled. Thus, these mini-chamber cell-charged systems
represent a viable, novel, and scale down approach for the
evaluation of complex 3D scaﬀolds, a microbioprocess strategy
for tissue engineering, and oﬀer opportunities to study drug
testing and therapeutics in a range of models of CNS injury and
disease.
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